Annual Revenue
$45.01 B
-$1.15 B-2.50%
31 December 2023
Summary:
Bristol-Myers Squibb annual revenue is currently $45.01 billion, with the most recent change of -$1.15 billion (-2.50%) on 31 December 2023. During the last 3 years, it has fallen by -$1.38 billion (-2.97%). BMY annual revenue is now -2.97% below its all-time high of $46.38 billion, reached on 31 December 2021.BMY Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$11.89 B
-$309.00 M-2.53%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly revenue is currently $11.89 billion, with the most recent change of -$309.00 million (-2.53%) on 30 September 2024. Over the past year, it has increased by +$415.00 million (+3.62%). BMY quarterly revenue is now -2.53% below its all-time high of $12.20 billion, reached on 30 June 2024.BMY Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$47.44 B
+$926.00 M+1.99%
30 September 2024
Summary:
Bristol-Myers Squibb TTM revenue is currently $47.44 billion, with the most recent change of +$926.00 million (+1.99%) on 30 September 2024. Over the past year, it has increased by +$2.43 billion (+5.40%). BMY TTM revenue is now at all-time high.BMY TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +3.6% | +5.4% |
| 3 y3 years | -3.0% | -0.8% | +2.3% |
| 5 y5 years | +72.1% | +49.7% | +81.4% |
BMY Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.0% | at low | -2.5% | +8.4% | at high | +5.6% |
| 5 y | 5 years | -3.0% | +72.1% | -2.5% | +49.7% | at high | +81.4% |
| alltime | all time | -3.0% | +495.5% | -2.5% | +615.5% | at high | +2410.4% |
Bristol-Myers Squibb Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $11.89 B(-2.5%) | $47.44 B(+2.0%) |
| June 2024 | - | $12.20 B(+2.8%) | $46.51 B(+2.1%) |
| Mar 2024 | - | $11.87 B(+3.4%) | $45.53 B(+1.2%) |
| Dec 2023 | $45.01 B(-2.5%) | $11.48 B(+4.7%) | $45.01 B(+0.2%) |
| Sept 2023 | - | $10.97 B(-2.3%) | $44.94 B(-0.6%) |
| June 2023 | - | $11.23 B(-1.0%) | $45.19 B(-1.4%) |
| Mar 2023 | - | $11.34 B(-0.6%) | $45.85 B(-0.7%) |
| Dec 2022 | $46.16 B(-0.5%) | $11.41 B(+1.7%) | $46.16 B(-1.2%) |
| Sept 2022 | - | $11.22 B(-5.6%) | $46.74 B(-0.9%) |
| June 2022 | - | $11.89 B(+2.1%) | $47.14 B(+0.4%) |
| Mar 2022 | - | $11.65 B(-2.8%) | $46.96 B(+1.2%) |
| Dec 2021 | $46.38 B(+9.1%) | $11.98 B(+3.1%) | $46.38 B(+2.0%) |
| Sept 2021 | - | $11.62 B(-0.7%) | $45.47 B(+2.4%) |
| June 2021 | - | $11.70 B(+5.7%) | $44.38 B(+3.7%) |
| Mar 2021 | - | $11.07 B(+0.0%) | $42.81 B(+0.7%) |
| Dec 2020 | $42.52 B(+62.6%) | $11.07 B(+5.0%) | $42.52 B(+7.9%) |
| Sept 2020 | - | $10.54 B(+4.1%) | $39.40 B(+13.0%) |
| June 2020 | - | $10.13 B(-6.0%) | $34.86 B(+12.4%) |
| Mar 2020 | - | $10.78 B(+35.7%) | $31.01 B(+18.6%) |
| Dec 2019 | $26.14 B(+15.9%) | $7.95 B(+32.3%) | $26.14 B(+8.2%) |
| Sept 2019 | - | $6.01 B(-4.2%) | $24.17 B(+1.3%) |
| June 2019 | - | $6.27 B(+6.0%) | $23.86 B(+2.4%) |
| Mar 2019 | - | $5.92 B(-0.9%) | $23.29 B(+3.2%) |
| Dec 2018 | $22.56 B(+8.6%) | $5.97 B(+5.0%) | $22.56 B(+2.4%) |
| Sept 2018 | - | $5.69 B(-0.2%) | $22.04 B(+2.0%) |
| June 2018 | - | $5.70 B(+9.8%) | $21.60 B(+2.7%) |
| Mar 2018 | - | $5.19 B(-4.7%) | $21.04 B(+1.3%) |
| Dec 2017 | $20.78 B(+6.9%) | $5.45 B(+3.7%) | $20.78 B(+1.0%) |
| Sept 2017 | - | $5.25 B(+2.1%) | $20.57 B(+1.6%) |
| June 2017 | - | $5.14 B(+4.4%) | $20.24 B(+1.4%) |
| Mar 2017 | - | $4.93 B(-6.0%) | $19.96 B(+2.8%) |
| Dec 2016 | $19.43 B(+17.3%) | $5.24 B(+6.5%) | $19.43 B(+5.2%) |
| Sept 2016 | - | $4.92 B(+1.0%) | $18.47 B(+4.8%) |
| June 2016 | - | $4.87 B(+10.9%) | $17.62 B(+4.2%) |
| Mar 2016 | - | $4.39 B(+2.4%) | $16.91 B(+2.1%) |
| Dec 2015 | $16.56 B(+4.3%) | $4.29 B(+5.4%) | $16.56 B(+0.2%) |
| Sept 2015 | - | $4.07 B(-2.3%) | $16.53 B(+0.9%) |
| June 2015 | - | $4.16 B(+3.0%) | $16.38 B(+1.7%) |
| Mar 2015 | - | $4.04 B(-5.1%) | $16.11 B(+1.4%) |
| Dec 2014 | $15.88 B(-3.1%) | $4.26 B(+8.6%) | $15.88 B(-1.1%) |
| Sept 2014 | - | $3.92 B(+0.8%) | $16.06 B(-0.9%) |
| June 2014 | - | $3.89 B(+2.0%) | $16.21 B(-1.0%) |
| Mar 2014 | - | $3.81 B(-14.2%) | $16.36 B(-0.1%) |
| Dec 2013 | $16.39 B(-7.0%) | $4.44 B(+9.2%) | $16.39 B(+1.5%) |
| Sept 2013 | - | $4.07 B(+0.4%) | $16.14 B(+2.1%) |
| June 2013 | - | $4.05 B(+5.7%) | $15.81 B(-2.4%) |
| Mar 2013 | - | $3.83 B(-8.6%) | $16.20 B(-8.1%) |
| Dec 2012 | $17.62 B(-17.1%) | $4.19 B(+12.2%) | $17.62 B(-6.7%) |
| Sept 2012 | - | $3.74 B(-15.9%) | $18.88 B(-7.9%) |
| June 2012 | - | $4.44 B(-15.4%) | $20.49 B(-4.6%) |
| Mar 2012 | - | $5.25 B(-3.7%) | $21.48 B(+1.1%) |
| Dec 2011 | $21.24 B(+9.0%) | $5.45 B(+2.0%) | $21.24 B(+1.6%) |
| Sept 2011 | - | $5.34 B(-1.6%) | $20.90 B(+2.7%) |
| June 2011 | - | $5.43 B(+8.4%) | $20.35 B(+3.4%) |
| Mar 2011 | - | $5.01 B(-2.0%) | $19.69 B(+1.0%) |
| Dec 2010 | $19.48 B(+3.6%) | $5.11 B(+6.5%) | $19.48 B(+0.4%) |
| Sept 2010 | - | $4.80 B(+0.6%) | $19.41 B(+0.1%) |
| June 2010 | - | $4.77 B(-0.8%) | $19.40 B(+0.5%) |
| Mar 2010 | - | $4.81 B(-4.5%) | $19.29 B(+2.6%) |
| Dec 2009 | $18.81 B(+6.2%) | $5.03 B(+5.1%) | $18.81 B(+16.5%) |
| Sept 2009 | - | $4.79 B(+2.6%) | $16.14 B(-2.8%) |
| June 2009 | - | $4.67 B(+7.9%) | $16.61 B(-3.1%) |
| Mar 2009 | - | $4.32 B(+82.6%) | $17.15 B(-3.2%) |
| Dec 2008 | $17.71 B(-8.4%) | $2.37 B(-54.9%) | $17.71 B(-17.8%) |
| Sept 2008 | - | $5.25 B(+1.0%) | $21.56 B(+3.1%) |
| June 2008 | - | $5.20 B(+6.4%) | $20.91 B(+3.6%) |
| Mar 2008 | - | $4.89 B(-21.3%) | $20.18 B(+2.9%) |
| Dec 2007 | $19.35 B(+12.1%) | $6.21 B(+35.0%) | $19.60 B(+15.7%) |
| Sept 2007 | - | $4.60 B(+2.9%) | $16.94 B(+2.7%) |
| June 2007 | - | $4.47 B(+3.6%) | $16.50 B(-2.4%) |
| Mar 2007 | - | $4.32 B(+21.4%) | $16.90 B(-2.1%) |
| Dec 2006 | $17.26 B(-7.3%) | $3.56 B(-14.4%) | $17.26 B(-4.8%) |
| Sept 2006 | - | $4.15 B(-14.7%) | $18.12 B(-3.3%) |
| June 2006 | - | $4.87 B(+4.2%) | $18.73 B(-0.1%) |
| Mar 2006 | - | $4.68 B(+5.9%) | $18.75 B(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2005 | $18.61 B(-4.0%) | $4.42 B(-7.3%) | $18.61 B(-3.8%) |
| Sept 2005 | - | $4.77 B(-2.5%) | $19.34 B(-0.1%) |
| June 2005 | - | $4.89 B(+7.9%) | $19.36 B(+0.4%) |
| Mar 2005 | - | $4.53 B(-12.1%) | $19.29 B(-0.5%) |
| Dec 2004 | $19.38 B(+3.9%) | $5.16 B(+7.9%) | $19.38 B(+9.8%) |
| Sept 2004 | - | $4.78 B(-0.9%) | $17.65 B(-3.3%) |
| June 2004 | - | $4.82 B(+4.2%) | $18.24 B(-1.7%) |
| Mar 2004 | - | $4.63 B(+35.1%) | $18.55 B(-0.5%) |
| Dec 2003 | $18.65 B(+3.0%) | $3.42 B(-36.3%) | $18.65 B(-6.8%) |
| Sept 2003 | - | $5.37 B(+4.7%) | $20.01 B(+4.4%) |
| June 2003 | - | $5.13 B(+8.5%) | $19.18 B(+5.5%) |
| Mar 2003 | - | $4.73 B(-1.1%) | $18.17 B(+0.4%) |
| Dec 2002 | $18.11 B(+0.7%) | $4.78 B(+5.4%) | $18.11 B(+0.9%) |
| Sept 2002 | - | $4.54 B(+9.9%) | $17.94 B(+0.2%) |
| June 2002 | - | $4.13 B(-11.5%) | $17.90 B(-3.1%) |
| Mar 2002 | - | $4.66 B(+1.1%) | $18.48 B(-0.2%) |
| Dec 2001 | $17.99 B(-1.3%) | $4.61 B(+2.5%) | $18.51 B(-0.9%) |
| Sept 2001 | - | $4.50 B(-4.4%) | $18.68 B(-0.3%) |
| June 2001 | - | $4.71 B(+0.4%) | $18.75 B(-2.9%) |
| Mar 2001 | - | $4.69 B(-2.0%) | $19.31 B(+1.2%) |
| Dec 2000 | $18.22 B(+7.9%) | $4.78 B(+4.8%) | $19.07 B(+1.0%) |
| Sept 2000 | - | $4.56 B(-13.5%) | $18.88 B(+2.0%) |
| June 2000 | - | $5.28 B(+18.5%) | $18.51 B(+2.0%) |
| Mar 2000 | - | $4.45 B(-3.0%) | $18.15 B(-2.2%) |
| Dec 1999 | $16.88 B(+12.1%) | $4.59 B(+9.5%) | $18.55 B(+18.7%) |
| Sept 1999 | - | $4.19 B(-14.8%) | $15.63 B(-2.1%) |
| June 1999 | - | $4.92 B(+1.4%) | $15.96 B(+3.2%) |
| Mar 1999 | - | $4.85 B(+192.1%) | $15.47 B(+2.7%) |
| Dec 1998 | $15.06 B(-9.8%) | $1.66 B(-63.3%) | $15.06 B(-15.6%) |
| Sept 1998 | - | $4.52 B(+2.1%) | $17.84 B(+2.1%) |
| June 1998 | - | $4.43 B(-0.4%) | $17.47 B(+2.1%) |
| Mar 1998 | - | $4.45 B(+0.1%) | $17.10 B(+2.4%) |
| Dec 1997 | $16.70 B(+10.9%) | $4.44 B(+7.0%) | $16.70 B(+3.0%) |
| Sept 1997 | - | $4.15 B(+2.1%) | $16.21 B(+2.6%) |
| June 1997 | - | $4.06 B(+0.5%) | $15.81 B(+2.4%) |
| Mar 1997 | - | $4.04 B(+2.3%) | $15.44 B(+2.5%) |
| Dec 1996 | $15.06 B(+9.4%) | $3.96 B(+5.6%) | $15.06 B(+2.4%) |
| Sept 1996 | - | $3.75 B(+1.3%) | $14.72 B(+2.3%) |
| June 1996 | - | $3.70 B(+0.7%) | $14.39 B(+1.8%) |
| Mar 1996 | - | $3.67 B(+1.7%) | $14.13 B(+2.7%) |
| Dec 1995 | $13.77 B(+14.9%) | $3.61 B(+5.7%) | $13.77 B(+2.7%) |
| Sept 1995 | - | $3.41 B(-0.9%) | $13.41 B(+3.7%) |
| June 1995 | - | $3.44 B(+4.4%) | $12.93 B(+3.8%) |
| Mar 1995 | - | $3.30 B(+1.6%) | $12.45 B(+3.9%) |
| Dec 1994 | $11.98 B(+5.0%) | $3.25 B(+10.8%) | $11.98 B(+2.2%) |
| Sept 1994 | - | $2.93 B(-1.3%) | $11.73 B(+0.6%) |
| June 1994 | - | $2.97 B(+4.8%) | $11.66 B(+1.5%) |
| Mar 1994 | - | $2.83 B(-5.3%) | $11.49 B(+0.7%) |
| Dec 1993 | $11.41 B(+2.3%) | $2.99 B(+4.6%) | $11.41 B(+5.6%) |
| Sept 1993 | - | $2.86 B(+2.1%) | $10.81 B(-2.2%) |
| June 1993 | - | $2.80 B(+1.7%) | $11.05 B(-0.7%) |
| Mar 1993 | - | $2.75 B(+15.3%) | $11.13 B(-0.3%) |
| Dec 1992 | $11.16 B(-0.0%) | $2.39 B(-23.0%) | $11.16 B(-4.7%) |
| Sept 1992 | - | $3.10 B(+7.7%) | $11.70 B(+3.0%) |
| June 1992 | - | $2.88 B(+3.5%) | $11.36 B(+1.3%) |
| Mar 1992 | - | $2.78 B(-5.2%) | $11.21 B(+0.4%) |
| Dec 1991 | $11.16 B(+8.3%) | $2.94 B(+6.5%) | $11.16 B(+1.8%) |
| Sept 1991 | - | $2.76 B(+1.0%) | $10.96 B(+1.2%) |
| June 1991 | - | $2.73 B(-0.2%) | $10.82 B(+2.3%) |
| Mar 1991 | - | $2.73 B(-0.0%) | $10.58 B(+2.7%) |
| Dec 1990 | $10.30 B(+12.1%) | $2.74 B(+4.3%) | $10.30 B(+3.8%) |
| Sept 1990 | - | $2.62 B(+5.6%) | $9.92 B(+3.1%) |
| June 1990 | - | $2.48 B(+1.1%) | $9.62 B(+2.6%) |
| Mar 1990 | - | $2.46 B(+4.2%) | $9.38 B(+2.1%) |
| Dec 1989 | $9.19 B(+7.4%) | $2.36 B(+1.7%) | $9.19 B(+2.4%) |
| Sept 1989 | - | $2.32 B(+3.4%) | $8.97 B(+1.4%) |
| June 1989 | - | $2.24 B(-0.9%) | $8.85 B(+1.6%) |
| Mar 1989 | - | $2.27 B(+5.6%) | $8.71 B(+1.7%) |
| Dec 1988 | $8.56 B(+13.2%) | $2.14 B(-2.4%) | $8.56 B(+3.1%) |
| Sept 1988 | - | $2.20 B(+4.5%) | $8.30 B(+3.8%) |
| June 1988 | - | $2.10 B(-0.8%) | $8.00 B(+2.7%) |
| Mar 1988 | - | $2.12 B(+12.0%) | $7.79 B(+3.0%) |
| Dec 1987 | $7.56 B | $1.89 B(0.0%) | $7.56 B(+33.3%) |
| Sept 1987 | - | $1.89 B(0.0%) | $5.67 B(+50.0%) |
| June 1987 | - | $1.89 B(0.0%) | $3.78 B(+100.0%) |
| Mar 1987 | - | $1.89 B | $1.89 B |
FAQ
- What is Bristol-Myers Squibb annual revenue?
- What is the all time high annual revenue for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly revenue?
- What is the all time high quarterly revenue for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly revenue year-on-year change?
- What is Bristol-Myers Squibb TTM revenue?
- What is the all time high TTM revenue for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM revenue year-on-year change?
What is Bristol-Myers Squibb annual revenue?
The current annual revenue of BMY is $45.01 B
What is the all time high annual revenue for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual revenue is $46.38 B
What is Bristol-Myers Squibb quarterly revenue?
The current quarterly revenue of BMY is $11.89 B
What is the all time high quarterly revenue for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly revenue is $12.20 B
What is Bristol-Myers Squibb quarterly revenue year-on-year change?
Over the past year, BMY quarterly revenue has changed by +$415.00 M (+3.62%)
What is Bristol-Myers Squibb TTM revenue?
The current TTM revenue of BMY is $47.44 B
What is the all time high TTM revenue for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM revenue is $47.44 B
What is Bristol-Myers Squibb TTM revenue year-on-year change?
Over the past year, BMY TTM revenue has changed by +$2.43 B (+5.40%)